Clinical Trials Related to Preeclampsia

Related studies linked through entity extraction aliases.

Women's Perspective on First-trimester Preeclampsia Screening

Status: UNKNOWN
Phase: N/A

Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Status: RECRUITING
Phase: NA

Efficiency of the Web-Based Support Program Based on the Health Promotion Model in Pregnant Women With Preeclampsia

Status: UNKNOWN
Phase: NA

Lisinopril for Renal Protection in Postpartum Preeclamptic Women

Status: WITHDRAWN
Phase: NA

Virtual Cardiac Wellness Program Following Hypertensive Disorders of Pregnancy

Status: UNKNOWN
Phase: NA

Molecular Screening Method for Preeclampsia (PREMOM)

Status: COMPLETED
Phase: N/A

Aspirin and Neutrophils in Preeclampsia

Status: COMPLETED
Phase: N/A

Social Risks-Focused Lifestyle Intervention to Reduce Preeclampsia (SAIL)

Status: COMPLETED
Phase: NA

Soluble Factors and Renal Outcome in Preeclampsia

Status: COMPLETED
Phase: N/A

Preeclamptic Pregnancy Care Education

Status: COMPLETED
Phase: NA

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

Status: COMPLETED
Phase: NA

Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

Status: UNKNOWN
Phase: NA

Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.

Status: COMPLETED
Phase: N/A

Preeclampsia and Contact Activation

Status: COMPLETED
Phase: N/A

Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring

Status: COMPLETED
Phase: NA

Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia

Status: WITHDRAWN
Phase: PHASE4

Risk Prediction Model of Preeclampsia

Status: UNKNOWN
Phase: N/A

The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia

Status: COMPLETED
Phase: N/A

sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.

Status: RECRUITING
Phase: NA

Hydroxychloroquine in Prevention of Preeclampsia

Status: COMPLETED
Phase: NA